News
Carlisle Medical Will Be Exhibiting At The Pennsylvania 25th Annual Workers’ Compensation Conference
Carlisle Medical will be exhibiting at the Pennsylvania 25th Annual Workers’ Compensation Conference on May…
Thanksgiving Luncheon for Penelope House
It was our honor to share a full Thanksgiving meal donation with Penelope House today….
New Medication Release of Symbravo
The FDA recently approved Symbravo® (meloxicam/rizatriptan) for the acute treatment of migraine with or without…
New Medication Release of Tonmya
The FDA has approved Tonmya (cyclobenzaprine HCl sublingual tablet) for the treatment of fibromyalgia in…
Carlisle Medical Will Be Exhibiting at the 2025 Alabama Workers Compensation Society Conference (AWCS)
Carlisle Medical Will Be Exhibiting at the 2025 Alabama Workers Compensation Society Conference (AWCS) on…
Launch of Generic Entresto (sacubitril/valsartan) Tablets
Generic Entresto (sacubitril/valsartan) has recently been approved by the FDA and released in 24mg/26mg, 49mg/51mg…
Nevada Adopts ODG Drug Formulary
Bipartisan legislation makes Nevada the thirteenth state to adopt an ODG tool for workers’ comp…
Carlisle Medical Will Be Exhibiting At The 2025 Florida RIMS Educational Conference
Carlisle Medical is excited to announce that we will be exhibiting at the 2025 Florida…
Carlisle Medical Will Be Exhibiting At The 2025 IWCI Annual Seminar
Carlisle Medical is excited to announce that we will be exhibiting at the 2025 IWCI…
Launch of Brilinta® (Ticagrelor) Tablets
Generic Brilinta® (Ticagrelor) has been approved by the FDA. Ticagrelor tablets are indicated to reduce…
